Literature DB >> 18780147

Structure-based CoMFA and CoMSIA study of indolinone inhibitors of PDK1.

Kirandeep Kaur1, Tanaji T Talele.   

Abstract

Phosphoinositide-dependent protein kinase-1 (PDK1) is a Ser/Thr kinase which phosphorylates and activates members of the AGC kinase group known to control processes such as tumor cell growth, protection from apoptosis, and tumor angiogenesis. In this paper, CoMFA and CoMSIA studies were carried out on a training set of 56 conformationally rigid indolinone inhibitors of PDK1. Predictive 3D QSAR models, established using atom fit alignment rule based on crystallographic-bound conformation, had cross-validated (r(cv)(2)) values of 0.738 and 0.816 and non-cross-validated (r(ncv)(2)) values of 0.912 and 0.949 for CoMFA and CoMSIA models, respectively. The predictive ability of the CoMFA and CoMSIA models was determined using a test set of 14 compounds, which gave predictive correlation coefficients (r(pred)(2)) of 0.865 and 0.837, respectively. Structure-based interpretation of the CoMFA and CoMSIA field properties provided further insights for the rational design of new PDK1 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780147     DOI: 10.1007/s10822-008-9235-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  21 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  AGC protein kinase phosphorylation and protein kinase C.

Authors:  P J Parker; S J Parkinson
Journal:  Biochem Soc Trans       Date:  2001-11       Impact factor: 5.407

3.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

4.  Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.

Authors:  Jing Yang; Peter Cron; Valerie M Good; Vivienne Thompson; Brian A Hemmings; David Barford
Journal:  Nat Struct Biol       Date:  2002-12

Review 5.  PTEN: The down side of PI 3-kinase signalling.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Cell Signal       Date:  2002-04       Impact factor: 4.315

Review 6.  3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.

Authors:  Peter Storz; Alex Toker
Journal:  Front Biosci       Date:  2002-04-01

Review 7.  PDK1, the master regulator of AGC kinase signal transduction.

Authors:  Alfonso Mora; David Komander; Daan M F van Aalten; Dario R Alessi
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

8.  Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.

Authors:  Imadul Islam; Judi Bryant; Yuo-Ling Chou; Monica J Kochanny; Wheeseong Lee; Gary B Phillips; Hongyi Yu; Marc Adler; Marc Whitlow; Elena Ho; Dao Lentz; Mark A Polokoff; Babu Subramanyam; James M Wu; Daguang Zhu; Richard I Feldman; Damian O Arnaiz
Journal:  Bioorg Med Chem Lett       Date:  2007-04-27       Impact factor: 2.823

9.  Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation.

Authors:  Jing Yang; Peter Cron; Vivienne Thompson; Valerie M Good; Daniel Hess; Brian A Hemmings; David Barford
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

10.  Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517.

Authors:  Imadul Islam; Greg Brown; Judi Bryant; Paul Hrvatin; Monica J Kochanny; Gary B Phillips; Shendong Yuan; Marc Adler; Marc Whitlow; Dao Lentz; Mark A Polokoff; James Wu; Jun Shen; Janette Walters; Elena Ho; Babu Subramanyam; Daguang Zhu; Richard I Feldman; Damian O Arnaiz
Journal:  Bioorg Med Chem Lett       Date:  2007-05-23       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.